Advertisement
YOU ARE HERE: LAT HomeCollectionsRadian International
IN THE NEWS

Radian International

MORE STORIES ABOUT:
FEATURED ARTICLES
BUSINESS
August 4, 1998 | Bloomberg News
Los Angeles-based Dames & Moore Group bought Radian International from industrial and agricultural products giant Dow Chemical Co. for $117 million in cash, expanding its process engineering business. Austin, Texas-based Radian generates annual revenue of about $300 million from the engineering, construction and information management services it sells to large chemical, petroleum and manufacturing companies, and to government agencies.
ARTICLES BY DATE
BUSINESS
August 4, 1998 | Bloomberg News
Los Angeles-based Dames & Moore Group bought Radian International from industrial and agricultural products giant Dow Chemical Co. for $117 million in cash, expanding its process engineering business. Austin, Texas-based Radian generates annual revenue of about $300 million from the engineering, construction and information management services it sells to large chemical, petroleum and manufacturing companies, and to government agencies.
Advertisement
BUSINESS
August 18, 1998 | Bloomberg News
Dames & Moore Group said its board elected Arthur Darrow chairman of the Los Angeles-based engineering, consulting and environmental services company, succeeding George Leal. Officials weren't immediately available to comment on a reason for the change or the date when it will be effective. Under Darrow's direction, Dames & Moore completed its acquisition of Radian International from Dow Chemical Co. for $117 million last month.
BUSINESS
January 29, 1999 | From Bloomberg News
Amgen Inc., the world's largest biotechnology company, said Thursday that its fourth-quarter earnings rose 33%, beating analysts' estimates, as sales of its blockbuster anemia drug Epogen soared. Net income for the period ended Dec. 31 rose to $239 million, or 90 cents a share, from $180 million, or 67 cents, a year earlier. Results beat the 84-cent average estimate of analysts surveyed by First Call Corp. Epogen sales rose 35% to $391 million from $289 million a year earlier.
Los Angeles Times Articles
|